1.
Pediatr Blood Cancer
; 69(4): e29433, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34767303
2.
Clin Case Rep
; 9(3): 1367-1370, 2021 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33768846
RESUMO
Patients with sickle cell disease are already at high risk for respiratory complications, which SARS-CoV-2 can rapidly worsen. The case emphasizes the importance of efficiently maximizing standard therapies in sickle cell patients with COVID-19.